The neurobiology of acetyl-L-carnitine.

  title={The neurobiology of acetyl-L-carnitine.},
  author={Giovanna Traina},
  journal={Frontiers in bioscience},
  • G. Traina
  • Published 1 June 2016
  • Biology
  • Frontiers in bioscience
A large body of evidence points to the positive effects of dietary supplementation of acetyl-L-carnitine (ALC). Its use has shown health benefits in neuroinflammation, which is a common denominator in a host of neurodegenerative diseases. ALC is the principal acetyl ester of L-Carnitine (LC), and it plays an essential role in intermediary metabolism, acting as a donor of acetyl groups and facilitating the transfer of fatty acids from cytosol to mitochondria during beta-oxidation. Dietary… 

Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update

The effects of ALC on the gut–liver–brain axis seem to identify the category of patients in which the new insights contribute most to the mechanisms of action of A LC, likely being the liver metabolism and the improvement of hepatic detoxifying mechanisms the primary targets.

Anxiolytic and anti-stress effects of acute administration of acetyl-L-carnitine in zebrafish

ALC presented anxiolytic effects in both novel tank and light/dark tests and prevented the anxiety-like behavior induced by an acute stressor (net chasing) and was able to prevent the lipid peroxidation induced by acute stress in the zebrafish brain.

Neuroprotective effect of mildronate and L-carnitine on the cognitive parameters of aged mice and mice with LPS-induced inflammation

It was shown that L-car partly improved the memory and decreased the extent of mtDNA damage in the hippocampus of mice with the LPS-induced inflammation, while MD had a better neuroprotective effect in the irreversible cognitive impairment in aged mice, possibly due to a deeper restructuring of metabolism and reduction of oxidative stress.

The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease

The data suggest that LC may act by maintaining mitochondrial function and by reducing the pTau level, and the use of LC can promote cell survival in the setting of the metabolic impairments commonly observed in AD.

Preventive Role of L-Carnitine and Balanced Diet in Alzheimer’s Disease

The introduction of foodstuffs rich in carnitine and the MIND diet or Carnitine supplementation of the AD patients may improve their functioning in everyday life.

L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors

Findings suggest that ALC induces analgesia in an animal model of FD by up-regulating mGlu2 receptors, and that analgesia is maintained by additional mechanisms after ALC withdrawal.

The Role of Lipids in Parkinson’s Disease

The authors' review corroborates a central role for most lipid classes, but the available information is fragmented, not always reproducible, and sometimes differs by sex, age or PD etiology of the patients, hinders drawing firm conclusions about causal or associative effects of dietary lipids or defects in specific steps of lipid metabolism in PD.

Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials

Preclinical studies of cell cultures and mouse models, as well as clinical studies in which the effect of therapies which reduce oxidative stress and mitochondrial alterations on the cognitive dysfunction associated with DS have been assessed, are summarized.



Update on critical evidence for use of carnitine analogs in clinical practice in CNS disorders

Evidence that carnitine analogs play many roles in serious diseases and treatments is summarized, suggesting that ALC can affect several targets in the central nervous system.

Cytoprotective Effect of Acetyl-l-Carnitine Evidenced by Analysis of Gene Expression in the Rat Brain

Results suggest that ALC might play a cytoprotective role against various brain stressors.

Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression

ALCAR is reported in double-blind controlled studies to have beneficial effects in major depressive disorders and Alzheimer's disease (AD), both of which are highly prevalent in the geriatric population.

Role of carnitine esters in brain neuropathology.

Identification of differentially expressed genes induced in the rat brain by acetyl-L-carnitine as evidenced by suppression subtractive hybridisation.

Carnitine derivatives: clinical usefulness

Carnitine represents a compound of great interest for its wide clinical application in various neurological disorders and may be of benefit in treating Alzheimer's dementia, depression in the elderly, HIV infection, chronic fatigue syndrome, peripheral neuropathies, ischemia and reperfusion of the brain, and cognitive impairment associated with various conditions.

Mechanisms of Ischemic Neuroprotection by Acetyl‐l‐carnitine

New experiments performed with primary cultures of rat cortical neurons indicate that the presence of acetyl‐l‐carnitine significantly inhibits both acute and delayed cell death following exposure to NMDA, an excitotoxic glutamate antagonist.

In the Rat Brain Acetyl-l-carnitine Treatment Modulates the Expression of Genes Involved in Neuronal Ceroid Lipofuscinosis

Evidence that ALC controls genes involved in these serious neurological pathologies is provided and insights into the ways in which ALC might exert its therapeutic benefits are provided.